25
Participants
Start Date
May 31, 2011
Primary Completion Date
December 31, 2013
Study Completion Date
May 31, 2015
Gemcitabine and Abraxane
3 treatments for gemcitabine and abraxane every 28-days for 3 months, prior to surgery.
University of Pittsburg Medical Center, Pittsburgh
St Mary's / Trinity Health Care, Grand Rapids
Virginia Piper Cancer Institute, Minneapolis
TGen Clinical Research Services at Scottsdale Healthcare, Scottsdale
Collaborators (1)
Celgene Corporation
INDUSTRY
Pancreatic Cancer Research Team
OTHER